European ADRs Move Lower in Thursday Trading

Shutterstock photo

American depositary receipts of European stocks were trading 1.11% lower at 127.97 on the Bank of New York Mellon Europe ADR Index on Thursday.

In continental Europe, the gainers were led by biotech firm Ascendis Pharma ( ASND ) and biopharmaceutical company DBV Technologies ( DBVT ), which rose which rose 2% and 1.9% respectively. They were followed by pharmaceutical company Grifols ( GRFS ) and consumer goods company Unilever ( UN ), which were up 1.2% and 0.8%.

The decliners in continental Europe were led by biotech company Zealand Pharma ( ZEAL ) and Deutsche Bank (DB), which were down 6.1% and 5.7% respectively. They were followed by pharmaceutical firm Sanofi (SAN), and financial services provider ING Groep (ING), which fell 4.4% and 3.9%.

In the UK and Ireland, the gainers were led by airplane leasing company Fly Leasing (FLY) and Trinity Biotech (TRIB), which climbed 10.6% and 5.4% respectively. They were followed by natural gas distributor National Grid (NGG) and alcoholic beverage company Diageo (DEO), which were up 1.3% and 0.7%.

The decliners in the UK and Ireland were led by specialty pharmaceuticals company Midatech Pharma (MTP) and biopharmaceutical firm NuCana (NCNA), which fell 10.9% and 3.9% respectively. They were followed by insurance firm Prudential (PUK) and Lloyds Banking Group (LYG), which were off 3% and 2.2%.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing , Stocks , ETFs
Referenced Symbols: ASND , DBVT , GRFS , UN , ZEAL

More from MT Newswires


MT Newswires

MT Newswires

Market News, Commodities

Research Brokers before you trade

Want to trade FX?